Showing results (361-370 of 4,039) with videos related to
Sort By:
Pageof 404
Pharmacoepidemiology and Drug Safety|February 24, 2006
Potential bias in pharmacoepidemiological studies due to the length of the drug free period: a study on antidepressant drug use in adults in the NetherlandsHelga Gardarsdottir, Eibert R Heerdink, Antoine C G EgbertsPharmacoepidemiology and Drug Safety|February 4, 2006
Achilles tendon rupture and its association with fluoroquinolone antibiotics and other potential risk factors in a managed care populationJohn D Seeger, William A West, Daniel Fife, et al.Pharmacoepidemiology and Drug Safety|February 27, 2008
The use of questionnaires for measuring patient-reported side effects of drugs: its importance and methodological challengesJuliet M Foster, Thys van der Molen, Manfred Caeser, et al.Pharmacoepidemiology and Drug Safety|January 18, 2008
Outpatient use of cardiovascular drugs during pregnancySusan E Andrade, Marsha A Raebel, Jeffrey Brown, et al.Pharmacoepidemiology and Drug Safety|March 5, 2008
Somnolence effects of antipsychotic medications and the risk of unintentional injuryQayyim Said, Elane M Gutterman, Myoung S Kim, et al.Pharmacoepidemiology and Drug Safety|March 8, 2008
Brand substitution or multiple switches per patient? An analysis of pharmaceutical brand substitution in AustraliaLisa M Kalisch, Elizabeth E Roughead, Andrew L GilbertPharmacoepidemiology and Drug Safety|April 3, 2008
For the majority of patients with diabetes blood pressure and lipid management is not in line with recommendations. Results from a large population-based cohort in GermanyElke Raum, Susanne Lietzau, Christa Stegmaier, et al.Pharmacoepidemiology and Drug Safety|December 7, 2007
Incidence of cardiovascular events in breast cancer patients receiving chemotherapy in clinical practiceMyrthe P P Sukel, Nancy S Breekveldt-Postma, Joëlle A Erkens, et al.Pharmacoepidemiology and Drug Safety|January 9, 2008
Use of granulocyte colony-stimulating factor (G-CSF) and outcome in patients with non-chemotherapy agranulocytosisL Ibáñez, M Sabaté, E Ballarín, et al.Pharmacoepidemiology and Drug Safety|January 9, 2008
Maternal characteristics associated with pregnancy exposure to FDA category C, D, and X drugs in a Canadian populationTubao Yang, Mark C Walker, Daniel Krewski, et al.Pageof 404